The Journal of family practice
-
Zeroing in on the right drug regimen requires a look at an agent's clinical benefits, tolerability profile, and risk of drug interactions, as well as the patient's comorbidities.
-
Review Meta Analysis
Should antenatal testing be performed in patients with a pre-pregnancy BMI ≥ 35?
Possibly. Elevated BMI is associated with an increased risk for stillbirth (strength of recommendation [SOR], B; cohort studies and meta-analysis of cohort studies). Three studies found an association between elevated BMI and stillbirth and one did not. However, no studies demonstrate that antenatal testing in pregnant people with higher BMIs decreases stillbirth rates, or that no harm is caused by unnecessary testing or resultant interventions.
-
Although COVID-19 vaccination remains at the forefront, ACIP has offered guidance on MMR, pneumococcal, influenza, and travel vaccines. Here's a round-up.